A Study to Assess the Long-term Safety of QVA149

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

The study is designed to provide long-term safety data for QVA149 in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Phase 3

Novartis Pharmaceuticals

Glycopyrrolate